Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRIDE: HSCT for Young Adults with Severe Sickle Cell Disease
NCT01565616Phase 2Completed
- Sponsor
- Emory University
- Start
- Mar 2012
- Primary completion
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan, fludarabine, antithymocyte globulin rabbit in sickle cell disease (SCD), sponsored by Emory University. Started Mar 2012; status: completed.
02
Drugs
busulfanfludarabineantithymocyte globulin rabbit
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01565616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01565616.